Clarissa Desjardins
Director/Board Member at BELLUS HEALTH
Net worth: 2 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roberto Bellini | M | 44 | 15 years | |
| Will Lewis | M | 55 | 12 years | |
| Francesco Bellini | M | 77 | 22 years | |
| Melvin Sharoky | M | 73 | 23 years | |
| Jeremy Martin | M | - | - | |
| Michael Smith | M | 47 | 10 years | |
| Ramzi Benamar | M | 51 | 4 years | |
| Yao Lee | M | 54 | 6 years | |
| Michel Bouvier | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Elizabeth Anderson | F | 66 | 6 years | |
| Eugene Jeffrey Sullivan | M | 59 | 9 years | |
| Roger Adsett | M | 55 | 8 years | |
| Youssef Bennani | M | 63 | 7 years | |
| Drayton Wise | M | 49 | 10 years | |
| Carol Schafer | F | 60 | 4 years | |
| Andreas Orfanos | M | - | 20 years | |
| Sébastien Roy | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Nancy Harrison | F | - |
Congruence Therapeutics, Inc.
 Congruence Therapeutics, Inc. BiotechnologyHealth Technology Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021.
McGill University
| 3 years |
| David Brennan | M | 70 | 10 years | |
| Robert Paré | M | 68 |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Pierre Larochelle | M | 52 | 15 years | |
| Elizabeth Douville | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | 1 years |
| Joseph Rus | M | 78 | 15 years | |
| Al Altomari | M | 65 | 12 years | |
| David McGirr | M | 69 | 11 years | |
| Robert A. Heft | M | 69 | 11 years | |
| Franklin Berger | M | 74 | 14 years | |
| Denis Garceau | M | 67 | 27 years | |
| Lori Birkenberger | F | - | 3 years | |
| Reena Colacot | F | - | 3 years | |
| Chuck Stanley | M | - | 2 years | |
| Sylvain Fortier | M | 59 |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Heidi Zod | F | - | 4 years | |
| William Brock | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Patrick Cossette | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Jean-François LePrince | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Eleanor Barisser | F | - | - | |
| Mandy Fahey | F | - | - | |
| Martina Flammer | M | 60 | 5 years | |
| Catherine Tittley | F | - | 2 years | |
| Walter R. Perkins | M | - | 14 years | |
| Marc Therrien | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Nicolas Matziorinis | M | - |
McGill University
| 36 years |
| Jean Royer | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| S. Schaeffer | F | 55 | 12 years | |
| Catherine Bonuccelli | M | - | 5 years | |
| Jeffrey Packman | M | 57 | 11 years | |
| Charles Grubsztajn | M | - |
Congruence Therapeutics, Inc.
Congruence Therapeutics, Inc. BiotechnologyHealth Technology Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021. | - |
| Tony Matzouranis | M | 51 | 14 years | |
| Joan Shaw | F | - | 4 years | |
| Frédéric Bouchard | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Sara Bonstein | F | 43 | 4 years | |
| Marie-Josée Coutu | F | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | 16 years |
| Jacques Bernier | M | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Tony di Paolo | M | - | 3 years | |
| Nathalie Chauret | F | - | 7 years | |
| Daniel Hetu | M | - |
Congruence Therapeutics, Inc.
Congruence Therapeutics, Inc. BiotechnologyHealth Technology Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021. | - |
| Marie-Josée Hébert | F | - |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | - |
| Sébastien Roy | M | 48 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| François Desjardins | M | 61 | 19 years | |
| Gillian Holcroft | F | - |
McGill University
| 8 years |
| Michael Singer | M | 60 |
McGill University
| 8 years |
| David Bonita | M | 48 | 6 years | |
| Christine Pellizzari | F | 56 | 8 years | |
| Allan Mandelzys | M | 58 | 6 years | |
| Jehangir Appoo | M | - |
McGill University
| 8 years |
| Laurence Nicole Mengin de Loyer | F | 56 |
McGill University
| 4 years |
| Lance Eckel | M | - |
McGill University
| 4 years |
| Guo Hua Chen | M | 60 |
McGill University
| 5 years |
| Pierre Carabin | M | - |
McGill University
| 5 years |
| Steve Satov | M | - |
McGill University
| 6 years |
| Mark Monaghan | M | - |
McGill University
| 11 years |
| Martin Tolar | M | 59 | 7 years | |
| Francois Nader | M | 67 | 5 years | |
| Kurt Stefan Victor Clulow | M | 53 |
McGill University
| 8 years |
| Steve Forte | M | 45 | 1 years | |
| Salvatore Ruscitti | M | - |
McGill University
| 8 years |
| David Mott | M | 58 | 3 years | |
| Steinar Johan Engelsen | M | 73 | 23 years | |
| Jean-François Pariseau | M | 54 | 6 years | |
| Stephan Robert Patten | M | - |
McGill University
| 9 years |
| Chad Williams | M | 58 |
McGill University
| 7 years |
| Bijan Moazami | M | - |
McGill University
| 4 years |
| Blaine Davis | M | 50 | 3 years | |
| Adam Shine | M | - |
McGill University
| 7 years |
| Pierre Legault | M | 63 | - | |
| Lit Mo Lee | M | 52 |
McGill University
| 4 years |
| Ewa Don-Siemion | F | 62 |
McGill University
| 4 years |
| Kendrick C. Fong | M | - |
McGill University
| 4 years |
| Laurent Biron | M | - |
McGill University
| 4 years |
| Stephan Scholl | M | 53 |
McGill University
| 4 years |
| Stephen Maris Andersons | M | - |
McGill University
| 4 years |
| Brigitte K. Catellier | F | - |
McGill University
| 3 years |
| George Rizk | M | - |
McGill University
| 4 years |
| Darren J. Tangen | M | 53 |
McGill University
| 4 years |
| Michael B. Ding | M | - |
McGill University
| 2 years |
| Sébastien Rhéaume | M | - |
McGill University
| 4 years |
| David A. Nordquist | M | - |
McGill University
| 2 years |
| Tim N. Foote | M | - |
McGill University
| 4 years |
| Janelle Anderson | M | 51 |
McGill University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 79 | 79.00% |
| United States | 21 | 21.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Clarissa Desjardins
- Personal Network
